Biologics and Biomarkers for Asthma, Chronic Urticaria and Nasal Polyposis
Immune Mechanisms
Friday, March 2, 2018: 4:00 PM-5:15 PM
Convention Center, South Concourse, Level 3, S320CD
1.25 CME/CE
Primary Moderators:
Paula J. Busse, MD FAAAAI
Gilda Varricchi

Learning Objectives:
  1. Describe biomarkers to characterize the phenotype and endotype of asthma, chronic urticaria and nasal polyposis
  2. Discuss the results of key clinical trials using biologics for asthma, chronic urticaria and nasal polyposis
  3. Describe the role of biomarkers in choosing patients for biologic therapies
4:00 PM
Precision Biologic Therapy for Severe Asthma
Thomas B. Casale, MD FAAAAI
4:20 PM
Question & Answer
4:25 PM
Utility of Biologics for Antihistamine-Resistant Chronic Spontaneous Urticaria
Marcus Maurer, MD
4:45 PM
Question & Answer
4:50 PM
Biologics for Nasal Polyposis
Claus Bachert, MD PhD
5:10 PM
Question & Answer
See more of: Session